2019 annual financial data
SAB Biotherapeutics 2019 Net margin
Direct answer
Net margin was -261.07%.
Operating income was -8,674,000 USD and net income was -8,986,000 USD.
Operating cash flow was -9,214,440 USD.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,442,000 USD
- Operating income
- -8,674,000 USD
- Net income
- -8,986,000 USD
- Operating cash flow
- -9,214,440 USD